Antigen Selection Articles & Analysis
4 news found
But the timeline for the development of some vaccine types is still grueling, spanning preclinical design, multiple trial phases, and complex manufacturing hurdles. With challenges like antigen selection, delivery optimization, and large-scale production, companies like Creative Biolabs are rare and indispensable partners for pharma and academic groups racing ...
NEC will apply its experience and capabilities in artificial intelligence-powered design of immunogens to identify novel vaccine antigens with broad reactivity against betacoronaviruses. The lead antigens will be selected iteratively and validated in preclinical studies against known betacoronaviruses that already pose a significant epidemic or ...
” About VAC2 VAC2 is an allogeneic, or non-patient specific “off-the-shelf,” cancer vaccine product candidate designed to stimulate patient immune responses to an antigen commonly expressed in cancerous cells but not in normal adult cells. VAC2, which is produced from a pluripotent cell technology using a directed differentiation method, is comprised of a ...
Part I is devoted to the entire IHC staining process, including pre-analytical factors, antigen retrieval, selection of the primary antibody, staining protocol optimization, detection methods, and digital pathology. ...